Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Hennessy

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 14, 2006
Use of health care databases in pharmacoepidemiologySean Hennessy
Pharmacoepidemiology and Drug Safety|August 19, 2004
Disproportionality analyses of spontaneous reportsSean Hennessy
Clinical Pharmacology and Therapeutics|March 6, 2025
Characterizing Treatment Effect Heterogeneity Using Real-World DataHaedi Thelen, Sean Hennessy
American Journal of Hypertension|November 6, 2020
Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World EvidenceSean Hennessy, Jordana B Cohen
Expert Review of Pharmacoeconomics & Outcomes Research|March 18, 2021
Use of prescription drug samples in the US and implications for pharmacoepidemiologic research: a systematic search of the literatureEmily K Acton, Sean Hennessy
JAMA Internal Medicine|January 7, 2015
Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindicationsJames H Flory, Sean Hennessy
Annual Review of Pharmacology and Toxicology|October 9, 2014
Improving postapproval drug safety surveillance: getting better information soonerSean Hennessy, Brian L Strom
Annals of Internal Medicine|July 21, 2004
Is improved survival a class effect of angiotensin-converting enzyme inhibitors?Sean Hennessy, Stephen E Kimmel
American Journal of Epidemiology|October 11, 2022
Real-World Trends in the Evaluation of Medical ProductsSean Hennessy, Jesse A Berlin
Drug Safety|December 17, 2014
Comment on: "Desideratum for evidence-based epidemiology"Sean Hennessy, Charles E Leonard
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Basic & Clinical Pharmacology & Toxicology|April 14, 2006
Use of health care databases in pharmacoepidemiologySean Hennessy
Pharmacoepidemiology and Drug Safety|August 19, 2004
Disproportionality analyses of spontaneous reportsSean Hennessy
Clinical Pharmacology and Therapeutics|March 6, 2025
Characterizing Treatment Effect Heterogeneity Using Real-World DataHaedi Thelen, Sean Hennessy
American Journal of Hypertension|November 6, 2020
Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World EvidenceSean Hennessy, Jordana B Cohen
Expert Review of Pharmacoeconomics & Outcomes Research|March 18, 2021
Use of prescription drug samples in the US and implications for pharmacoepidemiologic research: a systematic search of the literatureEmily K Acton, Sean Hennessy
JAMA Internal Medicine|January 7, 2015
Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindicationsJames H Flory, Sean Hennessy
Annual Review of Pharmacology and Toxicology|October 9, 2014
Improving postapproval drug safety surveillance: getting better information soonerSean Hennessy, Brian L Strom
Annals of Internal Medicine|July 21, 2004
Is improved survival a class effect of angiotensin-converting enzyme inhibitors?Sean Hennessy, Stephen E Kimmel
American Journal of Epidemiology|October 11, 2022
Real-World Trends in the Evaluation of Medical ProductsSean Hennessy, Jesse A Berlin
Drug Safety|December 17, 2014
Comment on: "Desideratum for evidence-based epidemiology"Sean Hennessy, Charles E Leonard
Pageof 27